Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yanagi

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Current Topics in Microbiology and Immunology|February 10, 2009
Measles virus receptorsY Yanagi, M Takeda, S Ohno, et al.
Nature|September 6, 2000
SLAM (CDw150) is a cellular receptor for measles virusH Tatsuo, N Ono, K Tanaka, et al.
The British Journal of Ophthalmology|January 21, 2006
A2e mediated phototoxic effects of endoilluminatorsY Yanagi, Y Inoue, W-D Jang, et al.
Archives of Virology|February 22, 2002
The measles virus hemagglutinin downregulates the cellular receptor SLAM (CD150)K Tanaka, H Minagawa, M F Xie, et al.
Archives of Virology|January 1, 1994
Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46Y Yanagi, H L Hu, T Seya, et al.
Journal of Virology|February 13, 2001
V domain of human SLAM (CDw150) is essential for its function as a measles virus receptorN Ono, H Tatsuo, K Tanaka, et al.
Journal of Medical Virology|April 4, 2000
Antibody-free virion titer greatly differs between hepatitis C virus genotypesY Kimura, K Hayashida, H Ishibashi, et al.
Japanese Journal of Cancer Research : Gann|December 16, 1998
In vivo efficacy and tumor-selective metabolism of amrubicin to its active metaboliteT Noguchi, S Ichii, S Morisada, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 1978
[Anti-inflammatory activity of SL-573 (author's transl)]Y Yanagi, H Awata, Y Koga, et al.
Japanese Journal of Cancer Research : Gann|December 16, 1998
Tumor-selective distribution of an active metabolite of the 9-aminoanthracycline amrubicinT Noguchi, S Ichii, S Morisada, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Current Topics in Microbiology and Immunology|February 10, 2009
Measles virus receptorsY Yanagi, M Takeda, S Ohno, et al.
Nature|September 6, 2000
SLAM (CDw150) is a cellular receptor for measles virusH Tatsuo, N Ono, K Tanaka, et al.
The British Journal of Ophthalmology|January 21, 2006
A2e mediated phototoxic effects of endoilluminatorsY Yanagi, Y Inoue, W-D Jang, et al.
Archives of Virology|February 22, 2002
The measles virus hemagglutinin downregulates the cellular receptor SLAM (CD150)K Tanaka, H Minagawa, M F Xie, et al.
Archives of Virology|January 1, 1994
Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46Y Yanagi, H L Hu, T Seya, et al.
Journal of Virology|February 13, 2001
V domain of human SLAM (CDw150) is essential for its function as a measles virus receptorN Ono, H Tatsuo, K Tanaka, et al.
Journal of Medical Virology|April 4, 2000
Antibody-free virion titer greatly differs between hepatitis C virus genotypesY Kimura, K Hayashida, H Ishibashi, et al.
Japanese Journal of Cancer Research : Gann|December 16, 1998
In vivo efficacy and tumor-selective metabolism of amrubicin to its active metaboliteT Noguchi, S Ichii, S Morisada, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 1978
[Anti-inflammatory activity of SL-573 (author's transl)]Y Yanagi, H Awata, Y Koga, et al.
Japanese Journal of Cancer Research : Gann|December 16, 1998
Tumor-selective distribution of an active metabolite of the 9-aminoanthracycline amrubicinT Noguchi, S Ichii, S Morisada, et al.
Pageof 11